Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
322.37
-10.01 (-3.01%)
At close: Apr 17, 2025, 4:00 PM
321.70
-0.67 (-0.21%)
After-hours: Apr 17, 2025, 4:00 PM EDT
Molina Healthcare Market Cap
Molina Healthcare has a market cap or net worth of $17.62 billion as of April 17, 2025. Its market cap has decreased by -20.27% in one year.
Market Cap
17.62B
Enterprise Value
16.19B
1-Year Change
-20.27%
Ranking
Category
Stock Price
$322.37
Market Cap Chart
Since July 2, 2003, Molina Healthcare's market cap has increased from $496.00M to $17.62B, an increase of 3,453.17%. That is a compound annual growth rate of 17.79%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2025 | 17.88B | 7.41% |
Dec 31, 2024 | 16.65B | -20.97% |
Dec 29, 2023 | 21.06B | 9.23% |
Dec 30, 2022 | 19.28B | 3.82% |
Dec 31, 2021 | 18.58B | 47.29% |
Dec 31, 2020 | 12.61B | 48.24% |
Dec 31, 2019 | 8.51B | 17.34% |
Dec 31, 2018 | 7.25B | 65.62% |
Dec 29, 2017 | 4.38B | 42.00% |
Dec 30, 2016 | 3.08B | -8.57% |
Dec 31, 2015 | 3.37B | 30.17% |
Dec 31, 2014 | 2.59B | 62.92% |
Dec 31, 2013 | 1.59B | 26.16% |
Dec 31, 2012 | 1.26B | 23.53% |
Dec 30, 2011 | 1.02B | 21.16% |
Dec 31, 2010 | 842.20M | 44.14% |
Dec 31, 2009 | 584.30M | 23.22% |
Dec 31, 2008 | 474.20M | -56.80% |
Dec 31, 2007 | 1.10B | 20.27% |
Dec 29, 2006 | 912.60M | 23.37% |
Dec 30, 2005 | 739.70M | -42.04% |
Dec 31, 2004 | 1.28B | 100.19% |
Dec 31, 2003 | 637.50M | 28.53% |
View and export this data all the way back to 2003.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 754.27B |
UnitedHealth Group | 415.38B |
Johnson & Johnson | 379.48B |
AbbVie | 306.02B |
Novo Nordisk | 284.50B |
Abbott Laboratories | 227.16B |
Novartis AG | 209.93B |
AstraZeneca | 208.11B |